[Lymphadenopathy in phenytoin treatment].
The authors report on a 20-year-old patient who developed hydantoin lymphadenopathy during treatment with diphenylhydantoin. The problems associated with clinical and histological delimination from malignant lymphomata are described by reference to the literature. Hydantoin lymphadenopathy is regarded as a drug-induced allergic and toxic process.
D000328:Adult; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000209:etiology / Q000473:pathology; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008199:Lymphadenitis / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D010672:Phenytoin / Q000009:adverse effects* / Q000627:therapeutic use
D010672:Phenytoin
Lymphadenopathie unter Phenytoinbehandlung.